期刊文献+

结核分枝杆菌酯酶Rv1400c原核表达及表达产物的酶活性分析 被引量:2

Prokaryotic Expression of Esterase Rv1400c from Mycobacterium tuberculosis and Determination of Expressed Product Enzyme Activity
原文传递
导出
摘要 为探究结核分枝杆菌酯酶Rv1400c活性,以进一步研究Rv1400c的结构和功能。以结核分枝杆菌H37Rv基因组DNA为模板,对 Rv1400c 基因进行扩增,并将其克隆到 pET28b (+)原核表达载体上,构建pET28b-Rv1400c重组质粒,然后将构建的重组质粒转化到BL21( DE3)表达菌株中,增菌后用IPTG进行诱导表达再用亲和层吸树脂法进行纯化,利用不同底物、不同pH、不同温度对纯化后的Rv1400c酯酶进行活性分析。结果表明:成功构建出pET28b-Rv1400c重组质粒;SDS-PAGE和Western blot显示,Rv1400c以包涵体形式表达,蛋白分子质量为39 ku;在对8种底物的筛选中发现Rv1400c在C2~C14中具有活性,其中以在C2中活性最好;在以C12为底物、pH 8?0、37℃条件下酯酶活性最高。 This study aims to explore the activity of esterase Rv1400c of Mycobacterium tuberculosis and do further researches on the structure and function of Rv1400c. The Rv1400c gene was amplified with PCR and cloned into pET-28b(+) prokaryotic expression vector by using Mycobacterium tuberculosis H37Rv genomic DNA as template. Recombinant plasmid of pET28b-Rv1400c was constructed and then translated into BL21 ( DE3 ) expression strain. It was induced to express with IPTG after bacterial splitting and then purified with Ni-NTA affinity chromatography method. Activi ty of the purified Rv1400c was analyzed with different substrates, pH and temperature of three directions. The results showed that recombinant plasmid of pET28b-Rv1400c was successfully constructed;SDS-PAGE and Western blot showed Rv1400c was expressed in inclusion bodies and molecular weight of the protein was 39 ku;The Rv1400c was found active within the range of C2 to C14 in the screening of eight kinds of substrates and the best activity was in C2;Esterase activity was the highest under the conditions of pH 80 and 37 ℃ when the C12 was the substrate.
出处 《吉林农业大学学报》 CAS CSCD 北大核心 2014年第6期701-706,共6页 Journal of Jilin Agricultural University
基金 国家国际科技合作专项(2011DFA32900) 国家自然科学基金项目(31100659 31272538) 国家重点基础研究发展计划项目[973计划(2012CB518801)] 长春市科技局项目[长科技合(2011239)]
关键词 结核分枝杆菌酯酶Rv1400c pET28b-Rv1400c重组质粒 包涵体 酯酶活性 esterase Rv1400c of Mycobacterium tuberculosis recombinant plasmid of pET28b-Rv1400c inclusion body esterase activity
  • 相关文献

参考文献2

二级参考文献14

  • 1郭设平,刘思国,张秀华,王春来,宫强,郭洋,邵美丽.牛分枝杆菌抗原MPB70、MPB83和ESAT-6的融合表达及重组蛋白的初步应用[J].畜牧兽医学报,2006,37(7):676-680. 被引量:27
  • 2TOLLEFSEN S,VORDEERMEIER M,ULSEN I,et al.DNAinjection in combination with electroporation:A novel methodfor vaccination of farmed ruminants[J].Scand J Immunol,2003,57(3):229-238.
  • 3BROCK I,WELDINGH K,LEYTEN S,et al.Specific T-cellepitopes for immunoassay-based diagnosis of Mycobacteriumtuberculosis infection[J].J Clin Microbiol,2004,42(6):2379-2387.
  • 4BRYCEM B,NATALIEA P,DENISEL K,et al.Differenti-ation between MycobacteriumbovisBCG-vaccinated and M.bo-vis-infected cattle by using recombinant mycobacterial antigens[J].Clin Diagn Lab Immunol,1999,6(1):1-5.
  • 5TEIXEIRA H C,ABRAMO C,MUNK M E.Immunologicaldiagnosis of tuberculosis:problems and strategies for success[J].J Bras Pneumol,2007,33(3):323-334.
  • 6IWA M LEN H,BERVEN F S,FLADMARK K E,et al.Com-prehensive analysis of exported proteins from Mycobacteriumtuberculosis H37Rv[J].Proteomics,2007,7(10):1702-1718.
  • 7ALEXANDER C,MAUE W,RAY W,et al.Analysis of im-mune responses directed toward a recombinant early secretoryantigenic target six-kilodalton protein-culture filtrate protein10fusion protein in Mycobacterium bovis-infected cattle[J].Infect Immun,2005,73(10):6659-6667.
  • 8YANG H L,ZHU Y Z,QIN J H,et al.In silico and mi-croarray-based genomic approaches to identifying potentialvaccine candidates against Leptospira interrogans[J].BMCGenomics,2006,7:293.
  • 9ANDERSEN P.Effective vaccination of mice against Myco-bacterium tuberculosis infection with a soluble mixture of se-creted mycobacterial proteins[J].Infect Immun,1994,62(6):2536-2544.
  • 10BUDDLE B M,RYAN T J,POLLOCK J M,et al.Use ofEAST-6in the interferon-γtest for diagnosis of bovine tuber-culosis following skin testing[J].Vet Microbiol,2001,80(1):37-46.

同被引文献31

  • 1薛莹,姜泓,高雪,柏银兰,师长宏,张海,徐志凯,李元.结核分枝杆菌Rv2450基因的克隆、表达及纯化[J].第四军医大学学报,2004,25(19):1778-1781. 被引量:5
  • 2曾范得,王史玉,宋纪伟,等.鹿结核分枝杆菌流行株Rv3874.Rv3875融合荩㈥的克隆及原核表达[J].经济动物学报,2014-09-11.DOI:10.13326/j.jea.2014.1030.
  • 3Koch R. Die Aetiologie der Tubet'culose [ J ]. B#~rliner Kli- nische Wochenschrift, 1882,19 : 221-230.
  • 4Toilefsen S, Vordeermeier M, Ulsen 1, el al. DNA injection in combination wilh electroporation :A novel method for vaccina- tion of farmed ruminants ~ J] .Stand J lmmunol, 2003,57( 3 ) : 229-238.
  • 5l)u~ati R, Ruffiuo-Netto A, Basso 1,, et al. The r~sumption of consumption-a review on tuberculosis [ J ]. Mere Inst Oswaldo Cruz,2006, 101 (7) :697-714.
  • 6l,u M X. The tubt~rculosis epidemic situation and prevention measuresE J ]. Journal of China Traditional C'hint,sc Medicine lnhlrmalion ,2012,44(4) :73-74.
  • 7Zumla A, N ahid P, Cole S T.et al.Advances in the development of new tuberculosis drugs and treatment regimens [ J ]. Nat Rew Drug Discow ,2013,12(5) :388-404.
  • 8Dillon D C,Alderson M R,Day C H,et al.Moleeular and immu- nological characterization of Mycobacterium tuberculosis CEP- 10, an immunodiagnostic antigen misssing in Mycobacterium [ J ]. Clim Microbiol, 2003,38 ( 5 ) : 3285-3290.
  • 9Liebana E, Aranaz A, Francis B, et al. Assessment of genetic marke~ for species differentiation within the Mycobacterium tu- bewulosi.~ complex [ J 7. Clin Microbiol, 1996,34 (4) : 933-938.
  • 10沈国妙.结核病复发及结核分枝杆菌耐药机制的研究[J].复旦大学,2006,37(7):676-680.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部